Premarket movers: Magnificent Seven stocks are mostly lower: Apple (AAPL) slips 1% after after Loop Capital Markets downgraded the stock to hold, citing iPhone shipment reductions (Amazon (AMZN) -0.2%, Microsoft (MSFT) +0.4%, Tesla (TSLA) -0.4%, Alphabet (GOOGL) -0.3%, Nvidia (NVDA) -0.7%, Meta Platforms (META) -0.8%, Apple (AAPL) -1%) 3M (MMM) rises 1.4% higher after topping Wall Street’s profit estimates and raising its full-year outlook for the second straight quarter. Alvotech (ALVO) jumps 7.4% after the US Food & Drug Administration approved a new manufacturing process for the drug Simlandi. Arhaus (ARHS) rises 4% after Piper Sandler upgraded the furniture company to overweight, writing that “a positive business inflection appears to be underway.” AST SpaceMobile (ASTS) falls more than 2% after Viasat petitioned the FCC to reject the company's request for additional overseas spectrum authority CoreWeave (CRWV) falls over 3% even after Cathie Wood's ARK bought the dip on Monday; the stock had rallied yesterday after Goldman upgraded it to Buy General Motors (GM) falls 7% after narrowing its full-year profit forecast. Halliburton (HAL) rises 3.7% after the oilfield services company reported third-quarter adjusted earnings per share that beat the average analyst estimate as drilling and evaluation revenue was higher than expected. The company also forecast mid-single digit revenue growth for 2027. Hertz (HTZ) climbs 7.1% after Oro Mobility, which is backed by the car rental company, secured an $80 million strategic equity investment from a consortium of investors, including Cohen Private Ventures. MSCI Inc. (MSCI) gains 6.5% after the index provider reported adjusted earnings per share for the third quarter that beat the average analyst estimate. Nebius (NBIS) drops more than 2%, tracking weakness across AI-related stocks NuScale Power (SMR) falls 7.2% after Barclays cut its recommendation on the nuclear reactor company to underweight as it sees risks from a lack of contracts. Rapport Therapeutics’ (RAPP) soars 34% after the drug developer said a mid-stage trial of its experimental therapy for acute bipolar mania met the primary endpoint. Shares have since pared gains to 28%. Solstice Advanced Materials (SOLS) gains 2.9% after the Financial Times reports that activist hedge fund Starboard Value has built a stake in the Honeywell spinoff, citing unidentified people familiar with the matter. 3M (MMM) in focus after signing a deal with Amazon that includes a warrant for 3.2 million shares, vesting up to $6 billion Analyst actions: BlackRock (BLK) raised to Buy at TD Cowen; TKO raised to Buy at Arete; Prologis (PLD) raised to Buy at Freedom Capital; Trex (TREX) raised to Buy at Stifel; Live Nation (LYV) cut to Sell at CFRA; Werner (WERN) cut to Neutral at Baird; nVent (NVT) initiated Overweight at JPMorgan